Travere Therapeutics, Inc. Common Stock
$59.44
▼ 1.18
(-1.95%)
Volume: 1,205,623
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
38
- 21d momentum -11.4%
- RSI 38
🎯
Pullback
62
- Near lower Bollinger band
- -7.5% vs 20MA
💎
Value
50
- No fundamental data
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)38.1
MACD-0.903
MA trendMixed
ATR4.10%
21d mom.-11.4%
63d mom.+1.0%
vs 20MA-7.5%
RVOL(20)0.80×
52w low · 22
52w high · 69
-13.5% from 52-week high
20d support 58
· resistance 69
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$5.7B
PER—
PBR233.02
PSR9.66
EPS$-0.46
ROE-177.2%
ROA-5.4%
Dividend yield0.00%
Debt/Equity24.58
EV/EBITDA270.55
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -5.29% | -11.44% | +1.00% | +112.89% | +143.51% | +50.40% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -8.95%, daily vol 2.07%. Travere Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.